Skip to content

Non-profit, St. Francis seek to cut drug costs

In the News

SALT LAKE CITY, Utah — Civica Rx, a health care initiative unveiled early this year as Project Rx, is continuing to work toward its goal of lowering prices and easing shortages of hospital medications through expanded use of generic drugs.

Since formation of the non-profit company was announced in January, more than 120 health organizations representing about a third of the nation’s hospitals have expressed interest in the program or made commitments to participate.

Civica Rx “governing members” include SSM Health, a Catholic-affiliated non-profit headquartered in St. Louis that owns St. Francis Hospital in Maryville.

SSM announced in August that it plans to sell the hospital to St. Joseph-based Mosaic Life Care, a process that is expected to last several months. It has not been disclosed if Mosaic has plans to join the Civica Rx consortium.

Other Civica Rx governing members include Catholic Health Initiatives, HCA Healthcare, Intermountain Healthcare, the Mayo Clinic, Providence St. Joseph Health and Trinity Health.

Together, these seven organizations, which represent about 500 U.S. hospitals, will offer leadership through the Civica Rx Board of Directors in addition to providing capital investment.

According to a release issued by St. Francis on Sept. 7, the U.S. Department of Veterans Affairs is working with Civica Rx with an eye toward joining the initiative. Other health systems involved with Civica are to be announced later this year.

According to the St. Francis release, Civica Rx has identified 14 generic hospital-administered drugs to be included in the company’s initial effort.

Plans call for an FDA-approved manufacturer to produce those drugs directly or sub-contract production to other approved organizations.

Martin VanTrieste, former chief quality officer for Amgen, one of the world’s largest pharmaceutical companies, has been named Civica Rx’s top executive officer. According to the release, he will serve without compensation.

“We are creating a public asset with a mission to ensure that essential generic medications are accessible and affordable,” VanTrieste said in a prepared statement.

“The fact that a third of the country’s hospitals have either expressed interest or committed to participate with Civica Rx shows a great need for this initiative. This will improve the situation for patients by bringing much needed competition to the generic drug market.”

Civica Rx officials say their initial task will be to stabilize the supply of essential shortage-ridden generic medications commonly administered by U.S. hospitals. The twin goals are to lower costs while ensuring the existence of predictable quantities of pharmaceuticals.

The release stated that the company expects to have its first products on the market as early as 2019.

Civica Rx is citing research showing that the manufacture and distribution of generic drugs could be carried out at a fraction of current costs, saving patients and healthcare systems hundreds of millions of dollars annually.

SSM Health brings health care services to communities across the Midwest through a system comprising more than 40,000 employees and 10,000 providers.

The SSM network currently operates 24 hospitals, more than 300 physician offices and outpatient clinics, 10 post-acute facilities, comprehensive home care and hospice services, a pharmacy benefit company, a health insurance company, an accountable care organization and virtual care services.

Leave a Comment